• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Smartphone Detection of Chronic Kidney Disease Could Save NHS $877M Over 5 Years

by Fred Pennic 04/29/2019 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Smartphone Detection of Chronic Kidney Disease Could Save NHS $877M Over 5 Years

Healthy.io, an Israeli-based provider of FDA-cleared smartphone-based urinalysis has announced the results from its early detection of chronic kidney disease (CKD) pilot study with 2,000 NHS patients with diabetes. The pilot found improved test compliance (raising responses to 72% among patients who had previously not responded to testing reminders) and discovered previously undiagnosed cases of CKD (10 percent of those who took the test).

Financial Impact of CKD for the NHS

With a staggering price tag of £1.5bn per year, Chronic Kidney Disease (CKD) is becoming a major challenge for the NHS. With 1/10 adults already suffering from it, 20 million at risk, and only 40% complying with annual testing guidelines – rising costs are inevitable.

Detecting Albumin (a form of Protein) in urine early on the journey helps avoid CKD complications. That’s why focusing on increased compliance with annual testing is highly effective from both an economic and clinical perspective. NHS Innovation Accelerator company Healthy.io has developed a system that allows patients to use their smartphone for a quick and easy Protein urine test at home (ACR). Testing is as simple as taking a selfie.

Patients use the Healthy.io ACR Home Based Urine Test Kit and a special smartphone app to scan an ACR urine test-strip in the comfort of their own home. Clinical grade findings are analyzed and securely sent to the patients existing electronic medical record for GP review.

UK Pilot Study Background & Results

This latest technology has been rolled out in partnership with Modality, a GP super-practice which treats 400,000 patients nationally. In total 2,196 patients with diabetes in the Hull and Airedale region who had not come into their GP surgery for the recommended test was encouraged to use the ACR test to look for early signs of chronic kidney disease.

Some 72% of patients who were issued the ACR home based test kit completed the test, resulting in 10% newly found cases of elevated Protein – indicating previously unknown kidney disease.

£678.49M ($877M USD) in Savings for the NHS Over Five Years

According to an analysis by the Analysis by the York Health Economics Consortium (YHEC) – a health consultancy and research organization –  if the test were adopted across the UK:

· £678.49M ($877M USD) in savings for the NHS over five years

· An additional 33,723 cases of CKD diagnosis, leading to better management of the condition, reduced progression and incidents of stroke, cardiovascular disease, and another excess cost.

· 1,361 fewer deaths from kidney disease over the same timeframe

· 11,376 fewer people having to face end-stage renal disease in the same time frame (this happens at the last stage of kidney disease when the kidneys fail and dialysis or a transplant are needed).

Why It Matters

“Our mission is to leverage the simplicity of the Selfie into a clinical-grade scan that drives higher compliance and reduced healthcare costs. We are proud to have partnered with the Modality team and receive such strong independent economic endorsement for the service and its potential at a national level. Ultimately, kidney disease is a huge healthcare issue both in the UK and across the world. More than 1.8 million people have been diagnosed with Chronic Kidney Disease in England and it’s estimated that there are about a million who are living with the condition but without diagnosis,” said Founder and CEO of Healthy.io, Yonatan Adiri.

“The ACR Home Based Urine Test Kit if adopted nationally in the UK could save millions of pounds each year spent on chronic kidney disease. More importantly, those at-risk patients including people living with diabetes and high blood pressure should be tested annually for early signs of Chronic Kidney Disease but many fail to get to their GP for that yearly test. The ACR kit could enable many more at risk people to test annually at the comfort of their homes, so driving compliance, tracking early kidney disease potential problems, which has got to be good news for patients and clinicians as it reduces possible health risks.”

YHEC found that using Healthy.io’s ACR self-test compared to standard care could save £472 ($610M USD) per patient over five years – with a scaled up saving to the NHS across the UK of £214.7M ($277M USD) over the same period, in patients with diabetes who weren’t keeping up with proper testing regimes.

In addition, Healthy.io’s ACR screening kit drove testing compliance to 71.8% in a previously non-compliant patient suffering group. Moreover, the study estimated that 3,463 cases of end-stage renal disease (ESRD) and 523 deaths would be prevented over five years with additional 22,946 cases of CKD being diagnosed for the diabetic population.  

The findings reflect a similar pilot program in the US with Geisinger and the National Kidney Foundation that found similar results.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Blood Pressure, diabetes, electronic medical record, FDA, Kidney Disease, NHS, risk

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |